全文获取类型
| 收费全文 | 5953篇 |
| 免费 | 299篇 |
| 国内免费 | 20篇 |
专业分类
| 耳鼻咽喉 | 32篇 |
| 儿科学 | 395篇 |
| 妇产科学 | 87篇 |
| 基础医学 | 499篇 |
| 口腔科学 | 190篇 |
| 临床医学 | 382篇 |
| 内科学 | 1238篇 |
| 皮肤病学 | 297篇 |
| 神经病学 | 297篇 |
| 特种医学 | 222篇 |
| 外科学 | 846篇 |
| 综合类 | 444篇 |
| 预防医学 | 271篇 |
| 眼科学 | 312篇 |
| 药学 | 462篇 |
| 中国医学 | 13篇 |
| 肿瘤学 | 285篇 |
出版年
| 2023年 | 39篇 |
| 2022年 | 79篇 |
| 2021年 | 176篇 |
| 2020年 | 78篇 |
| 2019年 | 157篇 |
| 2018年 | 195篇 |
| 2017年 | 137篇 |
| 2016年 | 162篇 |
| 2015年 | 192篇 |
| 2014年 | 224篇 |
| 2013年 | 242篇 |
| 2012年 | 402篇 |
| 2011年 | 459篇 |
| 2010年 | 279篇 |
| 2009年 | 222篇 |
| 2008年 | 279篇 |
| 2007年 | 327篇 |
| 2006年 | 265篇 |
| 2005年 | 235篇 |
| 2004年 | 223篇 |
| 2003年 | 165篇 |
| 2002年 | 184篇 |
| 2001年 | 126篇 |
| 2000年 | 133篇 |
| 1999年 | 117篇 |
| 1998年 | 81篇 |
| 1997年 | 68篇 |
| 1996年 | 72篇 |
| 1995年 | 67篇 |
| 1994年 | 46篇 |
| 1993年 | 22篇 |
| 1992年 | 77篇 |
| 1991年 | 69篇 |
| 1990年 | 48篇 |
| 1989年 | 44篇 |
| 1988年 | 68篇 |
| 1987年 | 48篇 |
| 1986年 | 42篇 |
| 1985年 | 45篇 |
| 1984年 | 38篇 |
| 1983年 | 27篇 |
| 1981年 | 18篇 |
| 1980年 | 18篇 |
| 1979年 | 22篇 |
| 1977年 | 19篇 |
| 1975年 | 18篇 |
| 1974年 | 26篇 |
| 1972年 | 27篇 |
| 1971年 | 19篇 |
| 1968年 | 18篇 |
排序方式： 共有6272条查询结果，搜索用时 15 毫秒
1.
SK Raina 《Journal of postgraduate medicine》2015,61(3):213-Sep;61(3):213
2.
Dan Azagury Tara E Mokhtari Luis Garcia Ulysses S Rosas Trit Garg Homero Rivas John Morton 《Surgery》2019,165(3):565-570
Background
Laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic adjustable gastric banding all lead to substantial weight loss in obese patients. Long-term weight loss can be highly variable beyond 1-year postsurgery. This study examines and compares the frequency distribution of weight loss and lack of treatment effect rates after laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic adjustable gastric banding.Methods
A total of 1,331 consecutive patients at a single academic institution were reviewed from a prospectively collected database. Preoperative data collected included demographics, body mass index, and percent excess weight loss. Postoperative BMI and %EWL were collected at 12, 24, and 36 months. Percent excess weight loss was analyzed by the percentiles of excess weight lost, and the distribution of percent excess weight loss was evaluated in 10% increments. Lack of a successful treatment effect was defined as <25% excess weight loss.Results
Of the 1,331 patients, 72.4% (963) underwent laparoscopic Roux-en-Y gastric bypass, 18.3% (243) laparoscopic sleeve gastrectomy, and 9.4%(125) laparoscopic adjustable gastric banding. Mean percent excess weight loss was greatest for laparoscopic Roux-en-Y gastric bypass, followed by laparoscopic sleeve gastrectomy, and then by laparoscopic adjustable gastric banding at every time point: at 2 years mean percent excess weight loss was 77.9± 24.4 for laparoscopic Roux-en-Y gastric bypass, 50.8 ± 25.8 for laparoscopic sleeve gastrectomy, and 40.8± 25.9 for laparoscopic adjustable gastric banding (P < .0001). The rates of a successful treatment effect s for laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic adjustable gastric banding were 0.9%, 5.2%, and 24.3% at 1 year; 0.3%, 11.1%, and 26.0% at 2 years; and 1.0%, 25.3%, and 30.2% at 3 years. At 1 year, the odds ratio of lack of a successful treatment effect of laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass was 6.305 (2.125–19.08; P?=?.0004), the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass was 36.552 (15.64–95.71; P < .0001), and the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic sleeve gastrectomy was 5.791 (2.519–14.599; P < .0001). At 2 years, the odds ratio for laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass increased to 70.7 (9.4–531.7; P < .0001), the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass increased to 128.1 (16.8–974.3; P < .0001), and the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic sleeve gastrectomy decreased to 1.8 (0.9–3.6; P?=?.09).Conclusion
This study emphasizes the existing variability in weight loss across bariatric procedures as well as in the lack of a treatment effect for each procedure. Although laparoscopic adjustable gastric banding has the greatest rate of a lack of a successful treatment effect, the rate remained stable over 3 years postoperatively. Laparoscopic sleeve gastrectomy showed a doubling in the rate of a lack of a successful treatment effect every year reaching 25% at year 3. The rates for lack of a successful treatment effect for laparoscopic Roux-en-Y gastric bypass remained stable at about 1% for the first 3 years postoperatively. 相似文献3.
4.
5.
Sameer Arora Kamal Shemisa Muthiah Vaduganathan Arman Qamar Ankur Gupta Sushil K. Garg Dharam J. Kumbhani Helen Mayo Houman Khalili Ambarish Pandey Sandeep R. Das 《Journal of the American College of Cardiology》2019,73(19):2454-2464
Ticagrelor is a cornerstone of modern antithrombotic therapy alongside aspirin in patients with acute coronary syndrome and after percutaneous coronary intervention. Adverse effects such as bleeding and dyspnea have been associated with premature ticagrelor discontinuation, which may limit any potential advantage of ticagrelor over clopidogrel. The randomized trials of ticagrelor captured adverse events, offering the opportunity to more precisely quantify these effects across studies. Therefore, a meta-analysis of 4 randomized clinical trials of ticagrelor conducted between January 2007 and June 2017 was performed to quantify the incidence and causes of premature ticagrelor discontinuation. Among 66,870 patients followed for a median 18 months, premature ticagrelor discontinuation was seen in 25%; bleeding was the most common cause of discontinuation followed by dyspnea. Versus the comparators, the relative risk of dyspnea-related discontinuation during follow-up was 6.4-fold higher, the relative risk of bleeding was 3.2-fold higher, and the relative risk of discontinuation due to any adverse event was 59% higher for patients receiving ticagrelor. Understanding these potential barriers to adherence to ticagrelor is crucial for informed patient-physician decision making and can inform future efforts to improve ticagrelor adherence. This review discusses the incidence, causes, and biological mechanisms of ticagrelor-related adverse effects and offers strategies to improve adherence to ticagrelor. 相似文献
6.
7.
8.
Sonoelasticity imaging of prostate cancer: in vitro results 总被引：2，自引：0，他引：2
9.
10.